The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients (Q28364886)

9

object named as

W W Ten Bokkel Huinink

0 references

author name string

M M Malingré

1

0 references

J H Schellens

2

0 references

O Van Tellingen

3

0 references

M Ouwehand

4

0 references

H A Bardelmeijer

5

0 references

H Rosing

6

0 references

F J Koopman

7

0 references

M E Schot

British Journal of Cancer

8

0 references

language of work or name

English

0 references

publication date

16 November 2001

0 references

published in

0 references

volume

85

0 references

issue

10

0 references

page(s)

1472-7

0 references

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

start time

1 November 2001

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363961

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363961

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363961

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363961

Taxanes: a new class of antitumor agents.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363961

Suspected anaphylactic reaction to Cremophor EL.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363961

Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363961

High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine

27 November 2018

1 reference

12 December 2020

Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography

1 reference

12 December 2020

Determination of polyoxyethyleneglycerol triricinoleate 35 (Cremophor EL) in plasma by pre-column derivatization and reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

Co-administration of cyclosporin enables oral therapy with paclitaxel

1 reference

12 December 2020

Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice

1 reference

12 December 2020

Coadministration of oral cyclosporin A enables oral therapy with paclitaxel

1 reference

12 December 2020

Phase I and pharmacokinetic study of oral paclitaxel

1 reference

12 December 2020

Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel

1 reference

12 December 2020

Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration

1 reference

12 December 2020

Relative performance of specific and nonspecific fluorescence polarization immunoassay for cyclosporine in transplant patients

1 reference

12 December 2020

Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography

1 reference

12 December 2020